ADT-OH synergistically enhanced the antitumor activity of celecoxib in human colorectal cancer cells.

Huangru XuPing LiHailin MaYuanhao TanXiaoyang WangFangfang CaiJiaqi XuHuisong SunHongqin ZhuangZi-Chun Hua

Published in: Cancer medicine (2023)

In general, our results provide a reasonable combination strategy of low-dose ADT-OH and celecoxib in the preclinical application of colorectal cancer.

Keyphrases

low dose
endothelial cells
high dose
induced pluripotent stem cells
pluripotent stem cells
bone marrow